ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

This American College of Cardiology/ American Heart Association/National Heart, Lung and Blood Institute (ACC/AHA/NHLBI) Clinical Advisory is intended to summarize for professionals the current understanding of statin use, focused on myopathy, and to provide updated recommendations for the appropriate use of statins, including cautions, contraindications, and safety monitoring for statin therapy. Its purpose is not to discourage the appropriate use of statins, which have life-saving potential in properly selected patients, particularly those with established coronary heart disease (CHD) and others at high risk for developing CHD. Included are recent myopathy information compiled by the FDA, information from clinical trials, and summaries from the recently released report of the Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program.

Item No.: 02-CLINADVSTATINS
Availability: PDF (102 kb) (Information about file types)
Format: Use for E-ITEMs with no NHLBI pub number : Black + White
Page Count: 6 pages
Subject: Cholesterol-Other Cholesterol
Audience: Health Professionals
Language: English
Size: 8.5 in. X 11 in.
Date of Publication: 2002

Customer Reviews

There are no customer reviews for this item.

Related Links

• Third Report of the Expert Panel on Detection, Evaluation, and Treatment of the High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary
• Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III Final Report)